Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Storb

Showing results (231-240 of 315) with videos related to

Pageof 32
Sort By:
Bone Marrow Transplantation|September 28, 2019
EASIX and mortality after allogeneic stem cell transplantationThomas Luft, Axel Benner, Tobias Terzer, et al.
British Journal of Haematology|April 27, 2012
Success of allogeneic marrow transplantation for children with severe aplastic anaemiaLauri M Burroughs, Ann E Woolfrey, Barry E Storer, et al.
Blood|July 1, 2020
Sirolimus with CSP and MMF as GVHD prophylaxis for allogeneic transplantation with HLA antigen-mismatched donorsBrian Kornblit, Barry E Storer, Niels S Andersen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 30, 2004
Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantationPaul J Martin, Ji Pei, Ted Gooley, et al.
Leukemia & Lymphoma|October 23, 2002
Curative therapy of advanced essential thrombocythemia or polycythemia vera by hemopoietic stem cell transplantationUwe Platzbecker, Ted Gooley, Claudio Anasetti, et al.
Blood|March 21, 2007
Stable trichimerism after marrow grafting from 2 DLA-identical canine donors and nonmyeloablative conditioningScott S Graves, William Hogan, Christian S Kuhr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2005
Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioningFrédéric Baron, Michael B Maris, Brenda M Sandmaier, et al.
Blood|April 4, 2002
A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host diseasePaul A Carpenter, Frederick R Appelbaum, Lawrence Corey, et al.
The New England Journal of Medicine|November 26, 2010
Reduced mortality after allogeneic hematopoietic-cell transplantationTed A Gooley, Jason W Chien, Steven A Pergam, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 6, 2010
Impact of recipient statin treatment on graft-versus-host disease after allogeneic hematopoietic cell transplantationMarcello Rotta, Barry E Storer, Rainer Storb, et al.
Pageof 32

Showing results (231-240 of 315) with videos related to

Sort By:
Pageof 32
Bone Marrow Transplantation|September 28, 2019
EASIX and mortality after allogeneic stem cell transplantationThomas Luft, Axel Benner, Tobias Terzer, et al.
British Journal of Haematology|April 27, 2012
Success of allogeneic marrow transplantation for children with severe aplastic anaemiaLauri M Burroughs, Ann E Woolfrey, Barry E Storer, et al.
Blood|July 1, 2020
Sirolimus with CSP and MMF as GVHD prophylaxis for allogeneic transplantation with HLA antigen-mismatched donorsBrian Kornblit, Barry E Storer, Niels S Andersen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 30, 2004
Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantationPaul J Martin, Ji Pei, Ted Gooley, et al.
Leukemia & Lymphoma|October 23, 2002
Curative therapy of advanced essential thrombocythemia or polycythemia vera by hemopoietic stem cell transplantationUwe Platzbecker, Ted Gooley, Claudio Anasetti, et al.
Blood|March 21, 2007
Stable trichimerism after marrow grafting from 2 DLA-identical canine donors and nonmyeloablative conditioningScott S Graves, William Hogan, Christian S Kuhr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2005
Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioningFrédéric Baron, Michael B Maris, Brenda M Sandmaier, et al.
Blood|April 4, 2002
A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host diseasePaul A Carpenter, Frederick R Appelbaum, Lawrence Corey, et al.
The New England Journal of Medicine|November 26, 2010
Reduced mortality after allogeneic hematopoietic-cell transplantationTed A Gooley, Jason W Chien, Steven A Pergam, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 6, 2010
Impact of recipient statin treatment on graft-versus-host disease after allogeneic hematopoietic cell transplantationMarcello Rotta, Barry E Storer, Rainer Storb, et al.
Pageof 32